{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:01:06Z","timestamp":1790092866448,"version":"4.0.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05928-z","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:40:37Z","timestamp":1790044837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathway-specific mechanisms, therapeutic applications, and toxicodynamic profile of acriflavine in cancer: a comprehensive review"],"prefix":"10.1007","author":[{"given":"Touseef","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yaseen","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-6703","authenticated-orcid":false,"given":"Adnan","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"5928_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/pharmaceutics6010137","volume":"6","author":"S Ait-Oudhia","year":"2014","unstructured":"Ait-Oudhia S, Mager D, Straubinger R (2014) Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology. Pharmaceutics 6:137\u2013174","journal-title":"Pharmaceutics"},{"key":"5928_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673\u2013683","journal-title":"Nat Rev Drug Discov"},{"key":"5928_CR3","unstructured":"Aslam I (2023) Design and synthesis of quaternized hyaluronic acid-quercetin-carrageenan nanocomplexes for anticancer drug delivery."},{"key":"5928_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1515\/tjb-2021-0085","volume":"46","author":"BE\u00d6 Bedir","year":"2021","unstructured":"Bedir BE\u00d6, Terzi E, \u015eim\u015fek E, Karaku\u015f \u0130, Uysal T, Ercan E, G\u00fcler \u00d6\u00d6 (2021) HIF-1 inhibitors: differential effects of acriflavine and echinomycin on tumor associated CA-IX enzyme and VEGF in melanoma. Turk J Biochem 46:679\u2013684","journal-title":"Turk J Biochem"},{"key":"5928_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/10937404.2025.2566495","volume":"29","author":"M Benito-Fuertes","year":"2026","unstructured":"Benito-Fuertes M, Rodr\u00edguez-Garraus A, Gasc\u00f3n-Corella S, Azqueta A, Lizarraga E, Gonz\u00e1lez-Pe\u00f1as E, Vettorazzi A (2026) Genotoxicity and mutagenicity of emerging mycotoxins: a systematic review. J Toxicol Environ Health B Crit Rev 29:236\u2013273","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"2","key":"5928_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/07391102.1992.10508650","volume":"10","author":"H Berman","year":"1992","unstructured":"Berman H, Sussman J, Joshua-Tor L, Revich G, Ripley L (1992) A structural model for sequence-specific proflavin-DNA interactions during in vitro frameshift mutagenesis. J Biomol Struct Dyn 10(2):317\u2013331","journal-title":"J Biomol Struct Dyn"},{"key":"5928_CR7","doi-asserted-by":"publisher","DOI":"10.25258\/ijddt.14.1.78","author":"R Bijwar","year":"2024","unstructured":"Bijwar R, Tare H (2024) Revolutionizing medicine: advances in polymeric drug delivery systems. Int J Drug Deliv Technol. https:\/\/doi.org\/10.25258\/ijddt.14.1.78","journal-title":"Int J Drug Deliv Technol"},{"key":"5928_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1135\/cccc19300383","volume":"2","author":"M Bogert","year":"1930","unstructured":"Bogert M, Hirschfelder A, Lauffer P (1930) Researches in the acridine series. The synthesis of isomers of proflavine and of neutral acriflavine. Collect Czech Chem Commun 2:383\u2013395","journal-title":"Collect Czech Chem Commun"},{"key":"5928_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/cpt.2602","volume":"113","author":"CJ Bowman","year":"2023","unstructured":"Bowman CJ, Becourt-Lhote N, Boulifard V, Cordts R, Corriol-Rohou S, Enright B, Erkman L, Harris J, Hartmann A, Hilpert J (2023) Science-based approach to harmonize contraception recommendations in clinical trials and pharmaceutical labels. Clin Pharmacol Ther 113:226\u2013245","journal-title":"Clin Pharmacol Ther"},{"key":"5928_CR10","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"5928_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s12274-016-1059-0","volume":"9","author":"M Broekgaarden","year":"2016","unstructured":"Broekgaarden M, Weijer R, Krekorian M, Ijssel B, Kos M, Alles L, Wijk A, Bik\u00e1di Z, Hazai E, Gulik T, Heger M (2016) Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes. Nano Res 9:1639\u20131662","journal-title":"Nano Res"},{"key":"5928_CR12","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.2147\/OTT.S245134","volume":"13","author":"A Bulle","year":"2020","unstructured":"Bulle A, Dekervel J, Deschuttere L, Nittner D, Van Cutsem E, Verslype C, Van Pelt J (2020) Anti-cancer activity of acriflavine as metabolic inhibitor of oxphos in pancreas cancer xenografts. OncoTargets Ther 13:6907\u20136916","journal-title":"OncoTargets Ther"},{"issue":"1","key":"5928_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2016.09.029","volume":"383","author":"J Cao","year":"2016","unstructured":"Cao J, Lin G, Gong Y, Pan P, Ya X, Huang P, Ying M, Hou T, He Q, Yang B (2016) DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine\u2019s p53-dependent synergistic anti-tumor efficiency with melphalan. Cancer Lett 383(1):115\u2013124","journal-title":"Cancer Lett"},{"key":"5928_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/psp4.12895","volume":"12","author":"S Catozzi","year":"2023","unstructured":"Catozzi S, Hill R, Li XM, Dulong S, Collard E, Ballesta A (2023) Interspecies and in vitro\u2010in vivo scaling for quantitative modeling of whole\u2010body drug pharmacokinetics in patients: application to the anticancer drug oxaliplatin. CPT Pharmacomet Syst Pharmacol 12:221\u2013235","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"5928_CR15","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1039\/C6AN02721K","volume":"142","author":"J Chen","year":"2017","unstructured":"Chen J, Hu Y, Lu Q, Wang P, Zhan H (2017) Molecular imaging of small molecule drugs in animal tissues using laser desorption postionization mass spectrometry. Analyst 142:1119\u20131124","journal-title":"Analyst"},{"key":"5928_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/psp4.12904","volume":"12","author":"H Cordes","year":"2023","unstructured":"Cordes H, Rapp H (2023) Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal species. CPT Pharmacomet Syst Pharmacol 12:311\u2013319","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"5928_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/0115734064378178250815080012","author":"K Dalvi","year":"2025","unstructured":"Dalvi K, Pawar S (2025) Recent advances in synthetic pathways and therapeutic potential of acridine and acridone derivatives. Med Chem. https:\/\/doi.org\/10.2174\/0115734064378178250815080012","journal-title":"Med Chem"},{"key":"5928_CR18","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1021\/cb500476q","volume":"9","author":"S Dana","year":"2014","unstructured":"Dana S, Prusty D, Dhayal D, Gupta M, Dar A, Sen S, Mukhopadhyay P, Adak T, Dhar S (2014) Potent antimalarial activity of acriflavine in vitro and in vivo. ACS Chem Biol 9:2366\u20132373","journal-title":"ACS Chem Biol"},{"key":"5928_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/LBR.0000000000000126","volume":"22","author":"O Danilevskaya","year":"2015","unstructured":"Danilevskaya O, Averyanov A, Lesnyak V, Chernyaev A, Sorokina A (2015) Confocal laser endomicroscopy for diagnosis and monitoring of pulmonary alveolar proteinosis. J Bronchology Interv Pulmonol 22:33\u201340","journal-title":"J Bronchology Interv Pulmonol"},{"key":"5928_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tranon.2016.11.008","volume":"10","author":"J Dekervel","year":"2016","unstructured":"Dekervel J, Bulle A, Windmolders P, Lambrechts D, Van Cutsem E, Verslype C, Van Pelt J (2016) Acriflavine inhibits acquired drug resistance by blocking the epithelial-to-mesenchymal transition and the unfolded protein response. Transl Oncol 10:59\u201369","journal-title":"Transl Oncol"},{"key":"5928_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tranon.2016.11.008","volume":"10","author":"J Dekervel","year":"2017","unstructured":"Dekervel J, Bulle A, Windmolders P, Lambrechts D, Van Cutsem E, Verslype C, van Pelt J (2017) Acriflavine inhibits acquired drug resistance by blocking the epithelial-to-mesenchymal transition and the unfolded protein response. Transl Oncol 10:59\u201369","journal-title":"Transl Oncol"},{"key":"5928_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/em.70022","volume":"66","author":"E Demuynck","year":"2025","unstructured":"Demuynck E, Vanhaecke T, Thienpont A, Cappoen D, Van Goethem F, Winkelman L, Beltman J, Murugadoss S, Olsen A-K, Marcon F, Bossa C, Shaikh S, Nikolopoulou D, Hatzi V, Pennings J, Luijten M, Adam-Guillermin C, Paparella M, Audebert M, Mertens B (2025) Advancing genotoxicity assessment by building a global AOP network. Environ Mol Mutagen 66:341\u2013366","journal-title":"Environ Mol Mutagen"},{"key":"5928_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/1061186X.2021.1999961","volume":"30","author":"X Deng","year":"2021","unstructured":"Deng X, Song Q, Zhang Y, Liu W, Hu H, Zhang Y (2021) Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy. J Drug Target 30:334\u2013347","journal-title":"J Drug Target"},{"key":"5928_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.5c00488","author":"Q Ding","year":"2025","unstructured":"Ding Q, Qi M, Li W, Li M, Xu J, Kim Y, Kim G, Dong B, Wang L, Kim JS (2025) Precision phototherapy enabled by decoding complex microenvironments. Acc Chem Res. https:\/\/doi.org\/10.1021\/acs.accounts.5c00488","journal-title":"Acc Chem Res"},{"key":"5928_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c21383","author":"Q Ding","year":"2026","unstructured":"Ding Q, Li M, Mei L, Hua S, Li Z, Mengji R, Chen R, Liu H, Kim G, Jia M, Wang B, Yin C, Fan Q, Zhou H, Hu W, Cui J, Kim J (2026) Immune-evasive NIR-II nanoplatforms for repeatable photodynamic therapy. J Am Chem Soc. https:\/\/doi.org\/10.1021\/jacs.5c21383","journal-title":"J Am Chem Soc"},{"key":"5928_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.2c01021","author":"E Eckenberger","year":"2023","unstructured":"Eckenberger E, Raczka T, Neuhuber W, Distel L, Klein S (2023) Acriflavine-functionalized silica@manganese ferrite nanostructures for synergistic radiation and hypoxia therapies. ACS Appl Bio Mater. https:\/\/doi.org\/10.1021\/acsabm.2c01021","journal-title":"ACS Appl Bio Mater"},{"key":"5928_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00979-2","author":"A El-Masry","year":"2023","unstructured":"El-Masry A, Zeid A (2023) Acriflavine: an efficient green fluorescent probe for sensitive analysis of aceclofenac in pharmaceutical formulations. BMC Chem. https:\/\/doi.org\/10.1186\/s13065-023-00979-2","journal-title":"BMC Chem"},{"key":"5928_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/09603271251361194","author":"E El-Waseif","year":"2025","unstructured":"El-Waseif E, Hazem S, El-Kashef D, Suddek G (2025) Acriflavine protects against LPS-induced sepsis via regulation of pyroptosis, inflammation, and endoplasmic reticulum stress. Hum Exp Toxicol. https:\/\/doi.org\/10.1177\/09603271251361194","journal-title":"Hum Exp Toxicol"},{"key":"5928_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-1110(91)90006-H","volume":"258","author":"LR Ferguson","year":"1991","unstructured":"Ferguson LR, Denny WA (1991) The genetic toxicology of acridines. Mutat Res Rev Genet Toxicol 258:123\u2013160","journal-title":"Mutat Res Rev Genet Toxicol"},{"key":"5928_CR30","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1183\/09031936.00062512","volume":"41","author":"F Fuchs","year":"2012","unstructured":"Fuchs F, Zirlik S, Hildner K, Schubert J, Vieth M, Neurath M (2012a) Confocal laser endomicroscopy for diagnosing lung cancer in vivo. Eur Respir J 41:1401\u20131408","journal-title":"Eur Respir J"},{"key":"5928_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102280","volume":"80","author":"KMJ Gao","year":"2023","unstructured":"Gao KMJ, Marshak-Rothstein A, Fitzgerald KA (2023) Type-1 interferon-dependent and-independent mechanisms in cyclic GMP\u2013AMP synthase\u2013stimulator of interferon genes-driven auto-inflammation. Curr Opin Immunol 80:102280","journal-title":"Curr Opin Immunol"},{"key":"5928_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203465","author":"G Gkasdaris","year":"2024","unstructured":"Gkasdaris G, Berthiller J, Guyotat J, Jouanneau E, Gallet C, Meyronet D, Thomas L, Cartalat S, Seyve A, Honnorat J, Ducray F, Picart T (2024) Is carmustine wafer implantation in progressive high-grade gliomas a relevant therapeutic option? Complication rate, predictors of complications and onco-functional outcomes in a series of 53 cases. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16203465","journal-title":"Cancers (Basel)"},{"key":"5928_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ma15217560","author":"L Goni","year":"2022","unstructured":"Goni L, Jafar Mazumder MA, Tripathy DB, Quraishi MA (2022a) Acridine and its derivatives: synthesis, biological, and anticorrosion properties. Materials (Basel). https:\/\/doi.org\/10.3390\/ma15217560","journal-title":"Materials (Basel)"},{"key":"5928_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ma15217560","volume":"15","author":"LK Goni","year":"2022","unstructured":"Goni LK, Jafar Mazumder MA, Tripathy DB, Quraishi MA (2022b) Acridine and its derivatives: synthesis, biological, and anticorrosion properties. Materials (Basel) 15:7560","journal-title":"Materials (Basel)"},{"key":"5928_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03395-x","author":"J Guo","year":"2025","unstructured":"Guo J, Wang M-F, Yuan S-J, Li K, Zhang Q, Lei H-M, Wu J-L, Li A-X, Xu Y, Chen X (2025) Photo-controlled co-delivery of verteporfin and acriflavine via platelets achieves potentiated glioblastoma-targeted photodynamic therapy. J Nanobiotechnology. https:\/\/doi.org\/10.1186\/s12951-025-03395-x","journal-title":"J Nanobiotechnology"},{"key":"5928_CR36","doi-asserted-by":"publisher","first-page":"119935","DOI":"10.1016\/j.biomaterials.2020.119935","volume":"243","author":"S Hackett","year":"2020","unstructured":"Hackett S, Fu J, Kim Y, Tsujinaka H, Shen J, Silva R, Khan M, Hafiz Z, Wang T, Shin M, Anders N, He P, Ensign L, Hanes J, Campochiaro P (2020) Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization. Biomaterials 243:119935\u2013119935","journal-title":"Biomaterials"},{"key":"5928_CR37","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","volume":"94","author":"J Hakkola","year":"2020","unstructured":"Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O (2020) Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol 94:3671\u20133722","journal-title":"Arch Toxicol"},{"key":"5928_CR38","doi-asserted-by":"publisher","first-page":"10052","DOI":"10.1111\/jcmm.15612","volume":"24","author":"R Hallal","year":"2020","unstructured":"Hallal R, Nehme R, Brachet-Botineau M, Nehme A, Dakik H, Deynoux M, Sbarba D, Levern Y, Zibara K, Gouilleux F, Mazurier F (2020) Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells. J Cell Mol Med 24:10052\u201310062","journal-title":"J Cell Mol Med"},{"key":"5928_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202500124","volume":"6","author":"D Han","year":"2026","unstructured":"Han D, Weitz IS, Slika H, Tyler B, Steckl AJ (2026) Combined delivery of CuO nanoparticles and HIF-1\u03b1 inhibitor acriflavine for synergistic local treatment of glioblastoma. Adv NanoBiomed Res 6:e202500124","journal-title":"Adv NanoBiomed Res"},{"issue":"1","key":"5928_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31\u201346","journal-title":"Cancer Discov"},{"key":"5928_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-023-00569-y","author":"M Haripriyaa","year":"2023","unstructured":"Haripriyaa M, Suthindhiran K (2023) Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery. Future J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-023-00569-y","journal-title":"Future J Pharm Sci"},{"key":"5928_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.02097.x","author":"S Hassan","year":"2011","unstructured":"Hassan S, Laryea D, Mahteme H, Felth J, Frykn\u00e4s M, Fayad W, Linder S, Rickardson L, Gullbo J, Graf W, P\u00e5hlman L, Glimelius B, Larsson R, Nygren P (2011) Novel activity of acriflavine against colorectal cancer tumor cells. Cancer Sci. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02097.x","journal-title":"Cancer Sci"},{"key":"5928_CR43","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621666210901112954","author":"R Hassan","year":"2021","unstructured":"Hassan R, Mohi-Ud-Din R, Dar MO, Shah AJ, Mir P, Shaikh M, Pottoo F (2021) Bioactive heterocyclic compounds as potential therapeutics in the treatment of gliomas: a review. Anti-Cancer Agents Med Chem. https:\/\/doi.org\/10.2174\/1871520621666210901112954","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"5928_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311437","volume":"36","author":"M Huynh","year":"2024","unstructured":"Huynh M, Vinck R, Gibert B, Gasser G (2024) Strategies for the nuclear delivery of metal complexes to cancer cells. Adv Mater 36:2311437","journal-title":"Adv Mater"},{"key":"5928_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500267","volume":"20","author":"L Janovec","year":"2025","unstructured":"Janovec L, Guck\u00fd A, Krochtov\u00e1 K, Michalkov\u00e1 R, Ku\u0161n\u00edrov\u00e1 K, Mi\u0161kufov\u00e1 V, J\u00e1ger D, Moj\u017ei\u0161 J, Ko\u017eurkov\u00e1 M (2025) Development of 2, 9\u2010disubstituted acridines as topoisomerase II\u03b1 inhibitors with strong anticancer activity: synthesis, biological evaluation, and in silico study. ChemMedChem 20:e202500267","journal-title":"ChemMedChem"},{"key":"5928_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/1878-0261.12458","volume":"13","author":"W Januszewicz","year":"2019","unstructured":"Januszewicz W, Fitzgerald R (2019) Early detection and therapeutics. Mol Oncol 13:599\u2013613","journal-title":"Mol Oncol"},{"key":"5928_CR47","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/1078-0432.CCR-20-4592","volume":"27","author":"R Jones","year":"2021","unstructured":"Jones R, Wagner A, Kawai A, Tamura K, Shahir A, Van Tine B, Mart\u00edn-Broto J, Peterson P, Wright J, Tap W (2021) Prospective evaluation of doxorubicin cardiotoxicity in advanced soft tissue sarcoma patients treated in the ANNOUNCE Phase 3 randomized trial. Clinical Cancer Research\u202f: an Official Journal of the American Association for Cancer Research 27:3861\u20133866","journal-title":"Clinical Cancer Research : an Official Journal of the American Association for Cancer Research"},{"key":"5928_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3040","author":"J Kendrick","year":"2023","unstructured":"Kendrick J, Oelke C, Laing C, Crossman L, Stow R, Webber C (2023) The changing landscape for human absorption, metabolism, and excretion: practical experiences from a data analysis of 500 studies. Clin Pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.3040","journal-title":"Clin Pharmacol Ther"},{"key":"5928_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01302-1","author":"S Khan","year":"2024","unstructured":"Khan S, Fatima K, Aisha S, Malik F (2024) Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal CCS. https:\/\/doi.org\/10.1186\/s12964-023-01302-1","journal-title":"Cell Commun Signal CCS"},{"key":"5928_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-46312-4","volume-title":"Principles of fluorescence spectroscopy","author":"JR Lakowicz","year":"2006","unstructured":"Lakowicz JR (2006) Principles of fluorescence spectroscopy. Springer"},{"key":"5928_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF02977621","volume":"30","author":"P Lee","year":"2007","unstructured":"Lee P, Shin D, Lee K, Song S, Yoo H, Moon D, Hong J, Chung Y (2007) Effects of guanosine on the pharmacokinetics of acriflavine in rats following the administration of a 1:1 mixture of acriflavine and guanosine, a potential antitumor agent. Arch Pharm Res 30:372\u2013380","journal-title":"Arch Pharm Res"},{"key":"5928_CR52","first-page":"3549","volume":"34","author":"CJ Lee","year":"2014","unstructured":"Lee CJ, Yue CH, Lin YY, Wu JC, Liu JY (2014) Antitumor activity of acriflavine in human hepatocellular carcinoma cells. Anticancer Res 34:3549\u20133556","journal-title":"Anticancer Res"},{"key":"5928_CR53","doi-asserted-by":"crossref","unstructured":"Lee A, Jin H-O, Haque M, Kim H-Y, Jung H, Park J, Kim I, Song J, Yoon H, Kim H-K, Han J, Park I, Kim KS, Park S (2021) Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT-263) in triple-negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. International Journal of Oncology 60","DOI":"10.3892\/ijo.2021.5292"},{"key":"5928_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0022-2836(61)80004-1","volume":"3","author":"LS Lerman","year":"1961","unstructured":"Lerman LS (1961) Structural considerations in the interaction of DNA and acridines. J Mol Biol 3:18-IN14","journal-title":"J Mol Biol"},{"key":"5928_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1073\/pnas.49.1.94","volume":"49","author":"LS Lerman","year":"1963","unstructured":"Lerman LS (1963) The structure of the DNA-acridine complex. Proc Natl Acad Sci U S A 49:94\u2013102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5928_CR56","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.foodchem.2017.06.050","volume":"237","author":"Y Li","year":"2017","unstructured":"Li Y, Wang A, Bai Y, Wang S (2017) Acriflavine-immobilized eggshell membrane as a new solid-state biosensor for Sudan I-IV detection based on fluorescence resonance energy transfer. Food Chem 237:966\u2013973","journal-title":"Food Chem"},{"key":"5928_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s44307-026-00097-9","author":"D Li","year":"2026","unstructured":"Li D, Wang T, Liu H, Yao Y, Lu T, Wang R, Jiang X, Zhang X, Sun M, Peng Y, Yang Y, Shao N, Ding D, Zhi F (2026) Acriflavine-empowered IR780-PTX albumin nanoparticles for reinforced synergistic photochemotherapy. Adv Biotechnol. https:\/\/doi.org\/10.1007\/s44307-026-00097-9","journal-title":"Adv Biotechnol"},{"key":"5928_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106185","volume":"129","author":"J Liang","year":"2022","unstructured":"Liang J, Zheng M-Z, Xu W, Chen Y, Tang P-P, Wu G, Zou P, Li H, Chen L (2022) Acriflavine and proflavine hemisulfate as potential antivirals by targeting Mpro. Bioorg Chem 129:106185","journal-title":"Bioorg Chem"},{"key":"5928_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14990-w","author":"A Mangraviti","year":"2017","unstructured":"Mangraviti A, Raghavan T, Volpin F, Skuli N, Gullotti D, Zhou J, Asnaghi L, Sankey E, Liu A, Wang Y, Lee D-H, Gorelick N, Serra R, Peters M, Schriefer D, Delaspre F, Rodriguez F, Eberhart C, Brem H, Olivi A, Tyler B (2017) HIF-1\u03b1- targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-14990-w","journal-title":"Sci Rep"},{"key":"5928_CR60","doi-asserted-by":"crossref","unstructured":"Marques D, Da Silva Lima L, De Oliveira Moraes Miranda JF, Santos C\u00c1DA, Da Cruz Filho I, De Lima MDCA (2024) Exploring the therapeutic potential of acridines: Synthesis, structure, and biological applications. Bioorganic chemistry 155: 108096","DOI":"10.1016\/j.bioorg.2024.108096"},{"issue":"9","key":"5928_CR61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0753-3322(99)80007-9","volume":"52","author":"G Math\u00e9","year":"1998","unstructured":"Math\u00e9 G, Triana K, Pontiggia P, Blanquet D, Hallard M, Morette C (1998) Data of pre-clinical and early clinical trials of acriflavine and hydroxy-methyl-ellipticine reviewed, enriched by the experience of their use for 18 months to 6 years in combinations with other HIV1 virostatics. Biomed Pharmacother 52(9):391\u2013396","journal-title":"Biomed Pharmacother"},{"key":"5928_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2020.10.005","author":"P McCrorie","year":"2020","unstructured":"McCrorie P, Mistry J, Taresco V, Lovato T, Fay M, Ward I, Ritchie A, Clarke P, Smith S, Marlow M, Rahman R (2020) Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours. Eur J Pharm Biopharm. https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.005","journal-title":"Eur J Pharm Biopharm"},{"key":"5928_CR63","doi-asserted-by":"crossref","unstructured":"Miranda TG, Bihain MFR, Pereira AKDS, Cavallini G, Pereira DH (2025) The role of DNA intercalators and acridine derivatives in cancer chemotherapy. Fine Chemical Engineering","DOI":"10.37256\/fce.6220256477"},{"key":"5928_CR64","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijpharm.2018.09.034","volume":"551","author":"Y Montigaud","year":"2018","unstructured":"Montigaud Y, Ucakar B, Krishnamachary B, Bhujwalla ZM, Feron O, Pr\u00e9at V, Danhier F, Gallez B, Danhier P (2018) Optimized acriflavine-loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer. Int J Pharm 551:322\u2013328","journal-title":"Int J Pharm"},{"key":"5928_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/17474124.2018.1399794","volume":"12","author":"D Moss","year":"2018","unstructured":"Moss D, Curley P, Kinvig H, Hoskins C, Owen A (2018) The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. Expert Rev Gastroenterol Hepatol 12:223\u2013236","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"5928_CR66","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejmech.2013.12.013","volume":"73","author":"G Muscia","year":"2014","unstructured":"Muscia G, Buldain G, As\u00eds S (2014) Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents. Eur J Med Chem 73:243\u2013249","journal-title":"Eur J Med Chem"},{"key":"5928_CR67","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.chembiol.2021.11.006","volume":"29","author":"V Napolitano","year":"2022","unstructured":"Napolitano V, D\u0105browska A, Schorpp K, Mour\u00e3o A, Barreto-Duran E, Benedyk M, Botwina P, Brandner S, Bostock M, Chykunova Y, Czarna A, Dubin G, Fr\u00f6hlich T, Hoelscher M, J\u0119drysik M, Matsuda A, Owczarek K, Pachota M, Plettenburg O, Potempa J, Rothenaigner I, Schlauderer F, S\u0142ysz K, Szczepa\u0144ski A, Mohn KG-I, Blomberg B, Sattler M, Hadian K, Popowicz G, Pyr\u0107 K (2022a) Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol 29:774\u2013784","journal-title":"Cell Chem Biol"},{"key":"5928_CR68","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.chembiol.2021.11.006","volume":"29","author":"V Napolitano","year":"2022","unstructured":"Napolitano V, D\u0105browska A, Schorpp K, Mour\u00e3o A, Barreto-Duran E, Benedyk M, Botwina P, Brandner S, Bostock M, Chykunova Y, Czarna A, Dubin G, Fr\u00f6hlich T, H\u00f6lscher M, J\u0119drysik M, Matsuda A, Owczarek K, Pachota M, Plettenburg O, Potempa J, Rothenaigner I, Schlauderer F, S\u0142ysz K, Szczepa\u0144ski A, Blomberg B, Sattler M, Hadian K, Popowicz G, Pyr\u0107 K (2022b) Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chem Biol 29:774\u2013784","journal-title":"Cell Chem Biol"},{"key":"5928_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/polym14010101","volume":"14","author":"T Nawaz","year":"2021","unstructured":"Nawaz T, Iqbal M, Khan BA, Nawaz A, Hussain T, Hosny KM, Abualsunun WA, Rizg WY (2021) Development and optimization of acriflavine-loaded polycaprolactone nanoparticles using Box-Behnken design for burn wound healing applications. Polymers 14:101","journal-title":"Polymers"},{"key":"5928_CR70","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1080\/10717544.2022.2136783","volume":"29","author":"T Nawaz","year":"2022","unstructured":"Nawaz T, Iqbal M, Khan B, Ahmed N, Nawaz A, Rasul A, Rizg W, Jali A, Ahmed R, Safhi A (2022) Polycaprolactone based pharmaceutical nanoemulsion loaded with acriflavine: optimization and in vivo burn wound healing activity. Drug Deliv 29:3233\u20133244","journal-title":"Drug Deliv"},{"key":"5928_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-015-0020-4","author":"B Obstoy","year":"2015","unstructured":"Obstoy B, Salaun M, Veresezan L, Sesbo\u00fc\u00e9 R, Bohn P, Boland F-X, Thiberville L (2015a) Safety and performance analysis of acriflavine and methylene blue for in vivo imaging of precancerous lesions using fibered confocal fluorescence microscopy (FCFM): an experimental study. BMC Pulm Med. https:\/\/doi.org\/10.1186\/s12890-015-0020-4","journal-title":"BMC Pulm Med"},{"key":"5928_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12890-015-0020-4","volume":"15","author":"B Obstoy","year":"2015","unstructured":"Obstoy B, Salaun M, Veresezan L, Sesbo\u00fc\u00e9 R, Bohn P, Boland FX, Thiberville L (2015b) Safety and performance analysis of acriflavine and methylene blue for in vivo imaging of precancerous lesions using fibered confocal fluorescence microscopy (FCFM): an experimental study. BMC Pulm Med 15:30","journal-title":"BMC Pulm Med"},{"issue":"21","key":"5928_CR73","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1016\/j.bmcl.2010.06.001","volume":"20","author":"M Patel","year":"2010","unstructured":"Patel M, Mali M, Patel S (2010) Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives. Bioorg Med Chem Lett 20(21):6324\u20136326","journal-title":"Bioorg Med Chem Lett"},{"key":"5928_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ph17030329","author":"P Patel","year":"2024","unstructured":"Patel P, Garala K, Singh S, Prajapati B, Chittasupho C (2024) Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17030329","journal-title":"Pharmaceuticals (Basel)"},{"key":"5928_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/nar\/gkw878","volume":"45","author":"G P\u00e9pin","year":"2016","unstructured":"P\u00e9pin G, Nejad C, Thomas B, Ferrand J, McArthur K, Bardin P, Williams B, Gantier M (2016) Activation of cGAS-dependent antiviral responses by DNA intercalating agents. Nucleic Acids Res 45:198\u2013205","journal-title":"Nucleic Acids Res"},{"key":"5928_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fddsv.2024.1460100","author":"L Pinzi","year":"2024","unstructured":"Pinzi L, Bisi N, Rastelli G (2024) How drug repurposing can advance drug discovery: challenges and opportunities. Frontiers in Drug Discovery. https:\/\/doi.org\/10.3389\/fddsv.2024.1460100","journal-title":"Frontiers in Drug Discovery"},{"key":"5928_CR77","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1021\/acs.jmedchem.2c00573","volume":"65","author":"K Pi\u00f3recka","year":"2022","unstructured":"Pi\u00f3recka K, Kurjata J, Stanczyk W (2022) Acriflavine, an acridine derivative for biomedical application: current state of the art. J Med Chem 65:11415\u201311432","journal-title":"J Med Chem"},{"key":"5928_CR78","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1021\/acs.jmedchem.2c00573","volume":"65","author":"K Piorecka","year":"2022","unstructured":"Piorecka K, Kurjata J, Stanczyk WA (2022) Acriflavine, an acridine derivative for biomedical application: current state of the art. J Med Chem 65:11415\u201311432","journal-title":"J Med Chem"},{"key":"5928_CR79","doi-asserted-by":"publisher","first-page":"21421","DOI":"10.1039\/D3RA02608F","volume":"13","author":"K Piorecka","year":"2023","unstructured":"Piorecka K, Kurjata J, Gostynski B, Kazmierski S, Stanczyk WA, Marcinkowska M, Janaszewska A, Klajnert-Maculewicz B (2023) Is acriflavine an efficient co-drug in chemotherapy? RSC Adv 13:21421\u201321431","journal-title":"RSC Adv"},{"issue":"6","key":"5928_CR80","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/004982598239353","volume":"28","author":"S Plakas","year":"1998","unstructured":"Plakas S, Said KE, Bencsath F, Musser S, Hayton W (1998a) Pharmacokinetics, tissue distribution and metabolism of acriflavine and proflavine in the channel catfish (Ictalurus punctatus). Xenobiotica; the Fate of Foreign Compounds in Biological Systems 28(6):605\u2013616","journal-title":"Xenobiotica; the Fate of Foreign Compounds in Biological Systems"},{"key":"5928_CR81","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/004982598239353","volume":"28","author":"SM Plakas","year":"1998","unstructured":"Plakas SM, el Said KR, Bencsath FA, Musser SM, Hayton WL (1998b) Pharmacokinetics, tissue distribution and metabolism of acriflavine and proflavine in the channel catfish (Ictalurus punctatus). Xenobiotica 28:605\u2013616","journal-title":"Xenobiotica"},{"key":"5928_CR82","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.gie.2005.05.021","volume":"62","author":"AL Polglase","year":"2005","unstructured":"Polglase AL, McLaren WJ, Skinner SA, Kiesslich R, Neurath MF, Delaney PM (2005) A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. Gastrointest Endosc 62:686\u2013695","journal-title":"Gastrointest Endosc"},{"key":"5928_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358","journal-title":"Nat Rev Drug Discov"},{"key":"5928_CR84","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1158\/1078-0432.CCR-16-1990","volume":"23","author":"R Ramanathan","year":"2017","unstructured":"Ramanathan R, Korn R, Raghunand N, Sachdev J, Newbold R, Jameson G, Fetterly G, Prey J, Klinz S, Kim J, Cain J, Hendriks B, Drummond D, Bayever E, Fitzgerald J (2017) Correlation between ferumoxytol uptake in tumor lesions by MRI and response to nanoliposomal irinotecan in patients with advanced solid tumors: a pilot study. Clin Cancer Res 23:3638\u20133648","journal-title":"Clin Cancer Res"},{"issue":"16","key":"5928_CR85","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1016\/j.bmcl.2014.06.047","volume":"24","author":"K Ramesh","year":"2014","unstructured":"Ramesh K, Pasha M (2014) Study on one-pot four-component synthesis of 9-aryl-hexahydro-acridine-1,8-diones using SiO2-I as a new heterogeneous catalyst and their anticancer activity. Bioorg Med Chem Lett 24(16):3907\u20133913","journal-title":"Bioorg Med Chem Lett"},{"key":"5928_CR86","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145\u2013166","journal-title":"Annu Rev Biochem"},{"key":"5928_CR87","doi-asserted-by":"crossref","unstructured":"Rosenberg N, Van Den Berg S, Stolwijk N, Jacobs B, Post H, Pasmooij A, De Visser S, Hollak C (2023) Access to medicines for rare diseases: a European regulatory roadmap for academia. Frontiers in Pharmacology 14","DOI":"10.3389\/fphar.2023.1142351"},{"key":"5928_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jat.3818","volume":"40","author":"D Sabolov\u00e1","year":"2020","unstructured":"Sabolov\u00e1 D, Kristian P, Ko\u017eurkov\u00e1 M (2020) Proflavine\/acriflavine derivatives with versatile biological activities. J Appl Toxicol 40:64\u201371","journal-title":"J Appl Toxicol"},{"key":"5928_CR89","volume":"12","author":"S Sadr","year":"2024","unstructured":"Sadr S, Hajjafari A, Rahdar A, Pandey S, Jafroodi PP, Lotfalizadeh N, Soroushianfar M, Kavasebi SS, Kharaba Z, Fathi-karkan S, Borji H (2024) Gold nanobiosensors and machine learning: pioneering breakthroughs in precision breast cancer detection. Eur J Med Chem Rep 12:100238","journal-title":"Eur J Med Chem Rep"},{"key":"5928_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106543","volume":"104","author":"S Sadr","year":"2025","unstructured":"Sadr S, Hajjafari A, Lotfalizadeh N, Lotfalizadeh M, Laein SS, Abbasi AM, Jafroodi PP, Roohbaksh Amooli Moghadam E, Rahdar A, Fathi-karkan S, Sohbatzadeh Z, Borji H, Kang M, Pandey S (2025) Phytosome-based nanotechnology for enhanced efficacy of anticancer phytocompounds: challenges and prospects. J Drug Deliv Sci Technol 104:106543","journal-title":"J Drug Deliv Sci Technol"},{"key":"5928_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.70076","volume":"31","author":"R Sakasai","year":"2026","unstructured":"Sakasai R, Iwabuchi K (2026) Processing of DNA topoisomerase II\u2013DNA\u2013protein crosslinks associated with anticancer drugs. Genes Cells 31:e70076","journal-title":"Genes Cells"},{"key":"5928_CR92","doi-asserted-by":"crossref","unstructured":"Sallais J, Park C, Alahari S, Porter T, Liu R, Kurt M, Farrell A, Post M, Caniggia I (2022) HIF1 inhibitor acriflavine rescues early-onset preeclampsia phenotype in mice lacking placental prolyl hydroxylase domain protein 2. JCI Insight 7","DOI":"10.1172\/jci.insight.158908"},{"key":"5928_CR93","doi-asserted-by":"crossref","unstructured":"Sander P, De Rossi E, Bo\u0308ddinghaus B, Cantoni R, Branzoni M, B\u00f6ttger E, Takiff H, Rodriquez R, L\u00f3pez G, Riccardi G (2000) Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS microbiology letters 193 1: 19\u201323","DOI":"10.1111\/j.1574-6968.2000.tb09396.x"},{"key":"5928_CR94","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.omtn.2022.01.016","volume":"27","author":"S Seredinski","year":"2022","unstructured":"Seredinski S, Boos F, G\u00fcnther S, Oo J, Warwick T, Ponce J, Lillich F, Proschak E, Knapp S, Gilsbach R, Pfl\u00fcger-M\u00fcller B, Brandes R, Leisegang M (2022) DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells. Mol Ther Nucleic Acids 27:1023\u20131035","journal-title":"Mol Ther Nucleic Acids"},{"key":"5928_CR95","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/echo.13245","volume":"33","author":"AY Shaikh","year":"2016","unstructured":"Shaikh AY, Suryadevara S, Tripathi A, Ahmed M, Kane JL, Escobar J, Cerny J, Nath R, McManus DD, Shih J (2016) Mitoxantrone-induced cardiotoxicity in acute myeloid leukemia\u2014a velocity vector imaging analysis. Echocardiography 33:1166\u20131177","journal-title":"Echocardiography"},{"key":"5928_CR96","volume-title":"Practical flow cytometry","author":"HM Shapiro","year":"2005","unstructured":"Shapiro HM (2005) Practical flow cytometry. John Wiley & Sons"},{"key":"5928_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1517\/17425255.2012.637916","volume":"8","author":"A Sharma","year":"2012","unstructured":"Sharma A, Madhunapantula S, Robertson G (2012) Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol 8:47\u201369","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5928_CR98","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, Schulz L, Widera M, Mehdipour AR, Tascher G (2020) Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587:657\u2013662","journal-title":"Nature"},{"key":"5928_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2022.112537","volume":"234","author":"WF Shuai","year":"2022","unstructured":"Shuai WF, Dong J, Wang N, Tao S, Du J, Hu S (2022) Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy. J Photochem Photobiol, B 234:112537","journal-title":"J Photochem Photobiol, B"},{"key":"5928_CR100","doi-asserted-by":"crossref","unstructured":"Sojka DR, Gogler A, Kania D, Vydra N, Wiecha K, Adamiec-Organi\u015bciok M, Wilk A, Chumak V, Maty\u015bniak D, Scieglinska D (2024) The human testis-enriched HSPA2 interacts with HIF-1\u03b1 in epidermal keratinocytes, yet HIF-1\u03b1 stability and HIF-1-dependent gene expression rely on the HSPA (HSP70) activity. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1871: 119735","DOI":"10.1016\/j.bbamcr.2024.119735"},{"key":"5928_CR101","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/00498250500188073","volume":"35","author":"S Song","year":"2005","unstructured":"Song S, Kwon O, Chung Y (2005) Pharmacokinetics and metabolism of acriflavine in rats following intravenous or intramuscular administration of AG60, a mixture of acriflavine and guanosine, a potential antitumour agent. Xenobiotica 35:755\u2013773","journal-title":"Xenobiotica"},{"key":"5928_CR102","doi-asserted-by":"crossref","unstructured":"Svajda L, Ran\u0111elovi\u0107 I, Surguta S, Baranyi M, Cserepes M, T\u00f3v\u00e1ri J (2024) Targeting hypoxia in combination with paclitaxel to enhance therapeutic efficacy in breast and ovarian cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 180: 117601","DOI":"10.1016\/j.biopha.2024.117601"},{"key":"5928_CR103","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2741\/3674","volume":"16","author":"K Takenaga","year":"2010","unstructured":"Takenaga K (2010) Angiogenic signaling aberrantly induced by tumor hypoxia. Front Biosci 16:31\u201348","journal-title":"Front Biosci"},{"key":"5928_CR104","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.210110","author":"M Tolba","year":"2021","unstructured":"Tolba M, Elmansi H (2021) Studying the quenching resulted from the formation of an association complex between olsalazine or sulfasalazine with acriflavine. R Soc Open Sci. https:\/\/doi.org\/10.1098\/rsos.210110","journal-title":"R Soc Open Sci"},{"key":"5928_CR105","volume-title":"Molecular fluorescence: principles and applications","author":"B Valeur","year":"2013","unstructured":"Valeur B, Berberan-Santos MN (2013) Molecular fluorescence: principles and applications. John Wiley & Sons"},{"key":"5928_CR106","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1080\/10837450.2021.1963276","volume":"26","author":"S Vandghanooni","year":"2021","unstructured":"Vandghanooni S, Rasoulian F, Eskandani M, Nakhjavani SA, Eskandani M (2021) Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties. Pharm Dev Technol 26:934\u2013942","journal-title":"Pharm Dev Technol"},{"key":"5928_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ph18091281","author":"AF Wali","year":"2025","unstructured":"Wali AF, Ansari AR, Mir PA, El-Tanani M, Babiker R, Hussain MS, Uppal J, Zargar AI, Mir RH (2025) Epigenetic alterations in hepatocellular carcinoma: mechanisms, biomarkers, and therapeutic implications. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18091281","journal-title":"Pharmaceuticals (Basel)"},{"key":"5928_CR108","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.18632\/oncotarget.6490","volume":"7","author":"R Weijer","year":"2015","unstructured":"Weijer R, Broekgaarden M, Krekorian M, Alles L, Van Wijk A, Mackaaij C, Verheij J, Van Der Wal A, Van Gulik T, Storm G, Heger M (2015) Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. Oncotarget 7:3341\u20133356","journal-title":"Oncotarget"},{"key":"5928_CR109","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nrc2501","volume":"8","author":"BG Wouters","year":"2008","unstructured":"Wouters BG, Koritzinsky M (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8:851\u2013864","journal-title":"Nat Rev Cancer"},{"key":"5928_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01808-1","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, Jin W (2024) Drug repurposing for cancer therapy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-024-01808-1","journal-title":"Signal Transduct Target Ther"},{"key":"5928_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16050619","volume":"16","author":"H Xie","year":"2024","unstructured":"Xie H, Xiao X, Yi X, Huang K, Wang L (2024) Cell-membrane-coated metal\u2013organic framework nanocarrier combining chemodynamic therapy for the inhibition of hepatocellular carcinoma proliferation. Pharmaceutics 16:619","journal-title":"Pharmaceutics"},{"key":"5928_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13102818.2022.2039077","volume":"36","author":"Z Yaneva","year":"2022","unstructured":"Yaneva Z, Ivanova D, Nikolova N, Toneva M (2022) Organic dyes in contemporary medicinal chemistry and biomedicine. I. From the chromophore to the bioimaging\/bioassay agent. Biotechnol Biotechnol Equip 36:1\u201314","journal-title":"Biotechnol Biotechnol Equip"},{"key":"5928_CR113","doi-asserted-by":"crossref","unstructured":"Yang J, Wang Z, Chenyan, Tang H, Hao H, Li M, Luo X, Yang M, Gao L, Li J (2024) Advances in Hydrogels of Drug Delivery Systems for the Local Treatment of Brain Tumors. Gels 10","DOI":"10.20944\/preprints202405.1419.v1"},{"key":"5928_CR114","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00706-013-1145-x","volume":"145","author":"I Ye\u015filda\u011f","year":"2014","unstructured":"Ye\u015filda\u011f I, Ulus R, Ba\u015far E, Aslan M, Kaya M, B\u00fclb\u00fcl M (2014) Facile, highly efficient, and clean one-pot synthesis of acridine sulfonamide derivatives at room temperature and their inhibition of human carbonic anhydrase isoenzymes. Monatsh Chem 145:1027\u20131034","journal-title":"Monatsh Chem"},{"key":"5928_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/cnma.202300384","volume":"10","author":"L Yin","year":"2024","unstructured":"Yin L, Zhang X, Diao S, Liu Y, Gu X, Zhou W, Xie C, Fan Q (2024) HIF-1\u03b1-inhibited nanophotosensitizers for near-infrared fluorescence imaging-guided enhanced photodynamic therapy. ChemNanoMat 10:e202300384","journal-title":"ChemNanoMat"},{"issue":"6","key":"5928_CR116","first-page":"10084","volume":"15","author":"P Zargar","year":"2018","unstructured":"Zargar P, Ghani E, Mashayekhi F, Ramezani A, Eftekhar E (2018) Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells. Oncol Lett 15(6):10084\u201310090","journal-title":"Oncol Lett"},{"key":"5928_CR117","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s11033-021-07087-1","volume":"49","author":"P Zargar","year":"2022","unstructured":"Zargar P, Koochakkhani S, Hassanzadeh M, Taziani YA, Nasrollahi H, Eftekhar E (2022) Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy. Mol Biol Rep 49:2755\u20132763","journal-title":"Mol Biol Rep"},{"key":"5928_CR118","first-page":"71","volume":"9","author":"B Zeynizadeh","year":"2019","unstructured":"Zeynizadeh B, Gilanizadeh M (2019) Microwave-promoted three-component Hantzsch synthesis of acridinediones under green conditions. Curr Chem Lett 9:71\u201378","journal-title":"Curr Chem Lett"},{"key":"5928_CR119","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40360-022-00564-8","volume":"23","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu Y, Yang F, Zhang J, Zhang J, Yu W, Wang M, Lv X, Li J, Bai T (2022) Interaction between AhR and HIF-1 signaling pathways mediated by ARNT\/HIF-1\u03b2. BMC Pharmacol Toxicol 23:26","journal-title":"BMC Pharmacol Toxicol"},{"key":"5928_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00682-7","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Yao M, Xia S, Zeng F, Liu Q (2025) Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cell Mol Biol Lett 30:2","journal-title":"Cell Mol Biol Lett"},{"key":"5928_CR121","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/03602532.2025.2462527","volume":"57","author":"A Zimmer","year":"2025","unstructured":"Zimmer A, Collier A (2025) Scaling factors to inform in vitro-in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations for development of missing data. Drug Metab Rev 57:91\u2013114","journal-title":"Drug Metab Rev"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05928-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:08:51Z","timestamp":1790089731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05928-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":121,"alternative-id":["5928"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05928-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"14 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"<b>Clinical trial number<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}